多发性肌炎与皮肌炎死亡率趋势:基于一般人群的研究
该研究利用加拿大不列颠哥伦比亚省行政健康数据库,纳入1997至2014年新发多发性肌炎(PM)和皮肌炎(DM)患者及匹配对照,比较早期(1997-2005)与晚期(2006-2014)队列的死亡率。结果显示PM和DM患者死亡率均下降,但相对风险无显著变化,绝对超额死亡率差异显著缩小。
要点
- PM与DM患者死亡率在晚期队列较早期下降,但相对风险仍高于对照人群。
- PM绝对死亡率差从32.6降至18.6每1000人年,交互P=0.02。
- DM呈现相似趋势,相对风险与绝对风险差均更高。
核心结论
- 近年PM或DM患者超额死亡率下降,但晚期队列仍存在相当大的过早死亡差距。
研究设计与样本
- 基于加拿大不列颠哥伦比亚省行政健康数据库的一般人群研究,识别新发PM/DM患者及最多10名年龄、性别和索引日期匹配的非PM/DM个体。
- PM和DM队列按诊断年份分为早期队列(1997-2005)和晚期队列(2006-2014)。
主要发现
- 早期队列PM和DM患者死亡率(每1000人年)高于晚期队列(PM:58.6 vs. 39.4;DM:80.6 vs. 51.3),对照人群改善较小(非PM:15.5 vs. 12.5;非DM:14.1 vs. 11.5)。
- PM多变量HR在早期和晚期分别为2.4(95% CI 1.7-3.4)和2.0(95% CI 1.4-2.9),交互P=0.62。
- PM绝对死亡率差早期为32.6(95% CI 20.8-44.4),晚期为18.6(95% CI 9.2-28.0),交互P=0.02。
- DM显示相似结果,HR和风险差更高。
临床怎么用
- 尽管PM/DM死亡率趋势改善,临床仍需关注患者残余超额死亡风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To evaluate mortality trends in polymyositis (PM) and dermatomyositis (DM) between January 1, 1997, and December 31, 2014. METHODS: Using an administrative health database from the province of British Columbia, Canada, we identified all patients with incident PM/DM and up to 10 age-, sex-, and index date matched non-PM/DM individuals. Study cohorts for both PM and DM were divided into two subgroups based on the year of diagnosis (i.e., early cohort [1997-2005] and late cohort [2006-2014]). Mortality rates, hazard ratios (HRs), and rate differences were compared between these cohorts. RESULTS: Mortality rates (per 1000 person-years) in the early cohorts for PM and DM patients were higher than those in the late cohorts (for PM: 58.6 vs. 39.4; for DM: 80.6 vs. 51.3), whereas smaller improvements were observed in the comparison cohorts (for non-PM: 15.5 vs. 12.5; for non-DM: 14.1 vs. 11.5). Corresponding to these two time periods, multivariable HRs for PM were 2.4 (95% CI, 1.7 to 3.4) and 2.0 (95% CI, 1.4 to 2.9), respectively (P-value for interaction=0.62). The corresponding absolute mortality rate differences were 32.6 (95% CI, 20.8 to 44.4) and 18.6 (95% CI, 9.2 to 28.0), respectively (P-value for interaction=0.02). Similar results with higher HRs and risk differences were seen in DM. CONCLUSIONS: In this general population study, we found a declining excess mortality in PM or DM patients in recent years, although there was a considerable residual premature mortality gap in the late cohort.
引用
- Li L, D'Silva KM, Lu N, et al. Mortality trends in polymyositis and dermatomyositis: A general population-based study. Semin Arthritis Rheum. 2020. PMID: 32896696. doi:10.1016/j.semarthrit.2020.08.009
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。